Embed this press release by copying the code below:
CMEA Portfolio Company Neos Therapeutics Acquires Rights to Generic Tussionex and Settles Litigation with Shire
CMEA Portfolio Company Neos Therapeutics Acquires Rights to Generic Tussionex and Settles Litigation with Shire